BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 12740532)

  • 1. Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma.
    Baena-Cagnani CE; Berger WE; DuBuske LM; Gurné SE; Stryszak P; Lorber R; Danzig M
    Int Arch Allergy Immunol; 2003 Apr; 130(4):307-13. PubMed ID: 12740532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion.
    Berger WE; Schenkel EJ; Mansfield LE;
    Ann Allergy Asthma Immunol; 2002 Nov; 89(5):485-91. PubMed ID: 12452207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.
    Nayak AS; Philip G; Lu S; Malice MP; Reiss TF;
    Ann Allergy Asthma Immunol; 2002 Jun; 88(6):592-600. PubMed ID: 12086367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis.
    Ciebiada M; Górska-Ciebiada M; DuBuske LM; Górski P
    Ann Allergy Asthma Immunol; 2006 Nov; 97(5):664-71. PubMed ID: 17165277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis.
    Raphael GD; Angello JT; Wu MM; Druce HM
    Ann Allergy Asthma Immunol; 2006 Apr; 96(4):606-14. PubMed ID: 16680933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.
    Di Lorenzo G; Pacor ML; Mansueto P; Esposito Pellitteri M; Lo Bianco C; Ditta V; Martinelli N; Rini GB
    J Allergy Clin Immunol; 2004 Sep; 114(3):619-25. PubMed ID: 15356567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
    Moinuddin R; deTineo M; Maleckar B; Naclerio RM; Baroody FM
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of desloratadine, 5 mg, compared with fexofenadine, 180 mg, in patients with symptomatic seasonal allergic rhinitis.
    Berger WE; Lumry WR; Meltzer EO; Pearlman DS
    Allergy Asthma Proc; 2006; 27(3):214-23. PubMed ID: 16913264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of desloratadine therapy on symptom scores and measures of nasal patency in seasonal allergic rhinitis: results of a single-center, placebo-controlled trial.
    Meltzer EO; Jalowayski AA; Vogt K; Iezzoni D; Harris AG
    Ann Allergy Asthma Immunol; 2006 Feb; 96(2):363-8. PubMed ID: 16498861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of desloratadine on use of rescue beta2-agonists and symptoms in patients suffering from seasonal allergic rhinitis and asthma].
    Kupczyk M; Bogacka E; Bocheńska-Marciniak M; Sterchaluk-Grzyb E; Tworek D; Kuna P
    Pol Merkur Lekarski; 2005 Feb; 18(104):129-32. PubMed ID: 17877115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis.
    Philip G; Nayak AS; Berger WE; Leynadier F; Vrijens F; Dass SB; Reiss TF
    Curr Med Res Opin; 2004 Oct; 20(10):1549-58. PubMed ID: 15462688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity.
    Busse WW; Casale TB; Dykewicz MS; Meltzer EO; Bird SR; Hustad CM; Grant E; Zeldin RK; Edelman JM
    Ann Allergy Asthma Immunol; 2006 Jan; 96(1):60-8. PubMed ID: 16440534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.
    Meltzer EO; Malmstrom K; Lu S; Prenner BM; Wei LX; Weinstein SF; Wolfe JD; Reiss TF
    J Allergy Clin Immunol; 2000 May; 105(5):917-22. PubMed ID: 10808172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose desloratadine and montelukast and allergen-induced late airway responses.
    Davis BE; Illamperuma C; Gauvreau GM; Watson RM; O'Byrne PM; Deschesnes F; Boulet LP; Cockcroft DW
    Eur Respir J; 2009 Jun; 33(6):1302-8. PubMed ID: 19164343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine.
    Ciebiada M; Ciebiada MG; Kmiecik T; DuBuske LM; Gorski P
    J Investig Allergol Clin Immunol; 2008; 18(5):343-9. PubMed ID: 18973097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 24-hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitis [ISRCTN32042139].
    Salmun LM; Lorber R
    BMC Fam Pract; 2002 Aug; 3():14. PubMed ID: 12162793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized study comparing the effect of loratadine added to montelukast with montelukast, loratadine, and beclomethasone monotherapies in patients with chronic asthma.
    Lu S; Liu N; Dass SB; Reiss TF
    J Asthma; 2009 Jun; 46(5):465-9. PubMed ID: 19544166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
    Bachert C
    Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of loratadine-montelukast on nasal congestion in patients with seasonal allergic rhinitis in an environmental exposure unit.
    Day JH; Briscoe MP; Ratz JD; Danzig M; Yao R
    Ann Allergy Asthma Immunol; 2009 Apr; 102(4):328-38. PubMed ID: 19441605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis.
    Pleskow W; Grubbe R; Weiss S; Lutsky B
    Ann Allergy Asthma Immunol; 2005 Mar; 94(3):348-54. PubMed ID: 15801245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.